+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cardiac POC Testing Devices - Global Market Trajectory & Analytics

  • PDF Icon

    Report

  • 377 Pages
  • October 2022
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5139739

Global Cardiac POC Testing Devices Market to Reach $1.8 Billion by 2027

Amid the COVID-19 crisis, the global market for Cardiac POC Testing Devices estimated at US$1.2 Billion in the year 2020, is projected to reach a revised size of US$1.8 Billion by 2027, growing at a CAGR of 5.8% over the period 2020-2027. Cardiac Markers Test, one of the segments analyzed in the report, is projected to record 6.1% CAGR and reach US$1.3 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Analyzers segment is readjusted to a revised 5.1% CAGR for the next 7-year period.

The U.S. Market is Estimated at $451.1 Million, While China is Forecast to Grow at 7.4% CAGR

The Cardiac POC Testing Devices market in the U.S. is estimated at US$451.1 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$204.7 Million by the year 2027 trailing a CAGR of 7.4% over the period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4.6% and 5.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Select Competitors (Total 50 Featured)

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Alfa Scientific Designs, Inc.
  • American Screening Corporation, Inc.
  • BD Medical device company
  • Beckman Coulter Inc.
  • Biomerica, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • LifeSign LLC
  • Medtronic plc
  • Nano-Ditech Corporation
  • Nexus Dx, Inc.
  • Nova Biomedical Corporation
  • PTS Diagnostics
  • Sekisui Medical Co., Ltd.
  • Siemens Healthineers AG
  • Werfen Life Group

What's New for 2022?

  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to a digital archives and Research Platform
  • Complimentary updates for one year
Frequently Asked Questions about the Global Market for Cardiac POC Testing Devices

What is the estimated value of the Global Market for Cardiac POC Testing Devices?

The Global Market for Cardiac POC Testing Devices was estimated to be valued at $1.2 Billion in 2020.

What is the growth rate of the Global Market for Cardiac POC Testing Devices?

The growth rate of the Global Market for Cardiac POC Testing Devices is 6.0%, with an estimated value of $1.8 Billion by 2027.

What is the forecasted size of the Global Market for Cardiac POC Testing Devices?

The Global Market for Cardiac POC Testing Devices is estimated to be worth $1.8 Billion by 2027.

Who are the key companies in the Global Market for Cardiac POC Testing Devices?

Key companies in the Global Market for Cardiac POC Testing Devices include Abbott Laboratories, ACON Laboratories, Inc., Alfa Scientific Designs, Inc., American Screening Corporation, Inc., BD Medical device company, Beckman Coulter Inc., Biomerica, Inc., Bio and Danaher Corporation.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Cardiac POC Testing Devices - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • A Prelude to Cardiac POC Testing
  • Impact of Covid-19 and a Looming Global Recession
  • 2020 Marked as a Year of Disruption & Transformation
  • As the Race between the Virus & Vaccines Intensifies, Where is the World Economy Headed in 2021
  • World Economic Growth Projections (Real GDP, Annual % Change) for 2020 through 2022
  • Impact of COVID-19 on Cardiac POCT Testing Market
  • Global Market Prospects and Outlook
  • Cardiac POC Testing Market Set to Record Strong Growth Led by Advancements in Cardiac Marker Testing
  • Cardiac Marker Tests Dominate the Cardiac POC Testing Market
  • North America Corners Major Share, Asia-Pacific to Record Fastest Growth
  • Competition
  • Recent Market Activity
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence, Mounting Economic and Social Burden of Cardiovascular Disease to Drive Market Growth
  • Leading Causes of Mortality Worldwide: Number of Deaths in Millions & % Share of Deaths by Cause for 2017
  • Leading Causes of Mortality for Low-Income and High-Income Countries
  • Aging Global Population at High Risk of Cardiac Illnesses Present Favorable Outlook for Cardiac POC Testing Devices
  • Expanding Elderly Population Worldwide: Breakdown of Number of People Aged 65+ Years in Million by Geographic Region for the Years 2019 and 2030
  • Technological Advances to Drive the Cardiac POC Diagnostics Market
  • An Overview of Available Quantitative and Qualitative POC Devices for Measuring Multiple Cardiac Markers
  • Increasing Demand for Troponin Tests Drive the Cardiac POC Market
  • Evolution of the Troponin Assay
  • Implementation of Unique & new Troponin-Based Tests Helps in Diagnosing MI
  • Optimizing Novel Troponin Assay Benefits
  • Troponin Applications: A Promising Future
  • Brain Natriuretic Peptide (BNP) Test Registers Significant Growth
  • Myoglobin Test
  • Myoglobin Test
  • Cardiac Biomarker Play Critical Role in Stroke Diagnosis
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 2: World Historic Review for Cardiac POC Testing Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 3: World 15-Year Perspective for Cardiac POC Testing Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2021 & 2027
  • Table 4: World Recent Past, Current & Future Analysis for Cardiac Markers Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 5: World Historic Review for Cardiac Markers Test by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 6: World 15-Year Perspective for Cardiac Markers Test by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 7: World Recent Past, Current & Future Analysis for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 8: World Historic Review for Analyzers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 9: World 15-Year Perspective for Analyzers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 10: World Recent Past, Current & Future Analysis for Hospitals & Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 11: World Historic Review for Hospitals & Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 12: World 15-Year Perspective for Hospitals & Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 13: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 14: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 15: World 15-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
  • Table 16: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 17: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 18: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
  • Table 19: USA Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 20: USA Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 21: USA 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2021 & 2027
  • Table 22: USA Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 23: USA Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 24: USA 15-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
  • Table 25: Canada Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 26: Canada Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 27: Canada 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2021 & 2027
  • Table 28: Canada Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 29: Canada Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 30: Canada 15-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
  • Table 31: Japan Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 32: Japan Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 33: Japan 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2021 & 2027
  • Table 34: Japan Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 35: Japan Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 36: Japan 15-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
  • Table 37: China Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 38: China Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 39: China 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2021 & 2027
  • Table 40: China Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 41: China Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 42: China 15-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
  • Table 43: Europe Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 44: Europe Historic Review for Cardiac POC Testing Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 45: Europe 15-Year Perspective for Cardiac POC Testing Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2021 & 2027
  • Table 46: Europe Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 47: Europe Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 48: Europe 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2021 & 2027
  • Table 49: Europe Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 50: Europe Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 51: Europe 15-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
  • Table 52: France Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 53: France Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 54: France 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2021 & 2027
  • Table 55: France Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 56: France Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 57: France 15-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
  • Table 58: Germany Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 59: Germany Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 60: Germany 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2021 & 2027
  • Table 61: Germany Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 62: Germany Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 63: Germany 15-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
  • Table 64: Italy Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 65: Italy Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 66: Italy 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2021 & 2027
  • Table 67: Italy Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 68: Italy Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 69: Italy 15-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
  • Table 70: UK Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 71: UK Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 72: UK 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2021 & 2027
  • Table 73: UK Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 74: UK Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 75: UK 15-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
SPAIN
  • Table 76: Spain Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 77: Spain Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 78: Spain 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2021 & 2027
  • Table 79: Spain Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 80: Spain Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 81: Spain 15-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
RUSSIA
  • Table 82: Russia Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 83: Russia Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 84: Russia 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2021 & 2027
  • Table 85: Russia Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 86: Russia Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 87: Russia 15-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
  • Table 88: Rest of Europe Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 89: Rest of Europe Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 90: Rest of Europe 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2021 & 2027
  • Table 91: Rest of Europe Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 92: Rest of Europe Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 93: Rest of Europe 15-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
  • Table 94: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
  • Table 95: Asia-Pacific Historic Review for Cardiac POC Testing Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 96: Asia-Pacific 15-Year Perspective for Cardiac POC Testing Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2021 & 2027
  • Table 97: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 98: Asia-Pacific Historic Review for Cardiac POC Testing Devices by Segment - Cardiac Markers Test and Analyzers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 99: Asia-Pacific 15-Year Perspective for Cardiac POC Testing Devices by Segment - Percentage Breakdown of Value Sales for Cardiac Markers Test and Analyzers for the Years 2012, 2021 & 2027
  • Table 100: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 and % CAGR
  • Table 101: Asia-Pacific Historic Review for Cardiac POC Testing Devices by End-Use - Hospitals & Laboratories, Diagnostic Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
  • Table 102: Asia-Pacific 15-Year Perspective for Cardiac POC Testing Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals & Laboratories, Diagnostic Centers and Other End-Uses for the Years 2012, 2021 & 2027
AUSTRALIA
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2022 (E)
INDIA
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2022 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2022 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2022 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Cardiac POC Testing Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2022 (E)
IV. COMPETITION
  • Total Companies Profiled: 50

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • ACON Laboratories, Inc.
  • Alfa Scientific Designs, Inc.
  • American Screening Corporation, Inc.
  • BD Medical device company
  • Beckman Coulter Inc.
  • Biomerica, Inc.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche AG
  • LifeSign LLC
  • Medtronic plc
  • Nano-Ditech Corporation
  • Nexus Dx, Inc.
  • Nova Biomedical Corporation
  • PTS Diagnostics
  • Sekisui Medical Co., Ltd.
  • Siemens Healthineers AG
  • Werfen Life Group